Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, secures a spot on Fortune's 2025 list of the 100 Most ...

NEW YORK, NY-Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, has been named one of the 100 Most Powerful ...

Reshma Kewalramani, an Indian-origin CEO, leads Vertex Pharmaceuticals, a Fortune 500 biotech firm, after moving to the US at ...

Nvidia CEO and cofounder Jensen Huang is in No. 1 spot on Fortune’s 2025 list of the world’s 100 most powerful businesspeople ...

Kewalramani, CEO of Vertex Pharmaceuticals, joins Fortune's 100 Most Powerful People in Business. Ranked 62nd, she is the 1st ...

Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, has been named among Fortune’s 100 Most Powerful People in ...

The list, released by Fortune for only the second time, recognises individuals who are not only active in business but also ...

On Fortune’s list of the 100 Most Powerful People in Business, a Mumbai-born woman rubs shoulders with the likes of Mark Zuckerberg and Mukesh Ambani ...

Shantanu Narayen, Reshma Kewalramani, Neal Mohan, Mukesh Ambani and Gautam Adani also make the Fortune 100 Most Powerful ...

The outcome of the study was just one setback reported by Vertex as it updated investors on its second-quarter results, ...

I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.

Topline results reveal that VX-993 did not meet its primary endpoints, meaning Vertex will discontinue its development.